Abstract:Objective:To investigate the role and mechanism of nicotinamide riboside in obesity-related lipotoxic cardiomyopathy.Methods:Male C57BL/6N mice at 8 weeks of age were randomly divided into the normal diet group (control group), high-fat diet group, and high-fat diet with nicotinamide ribose group ( n=10 each). The mice on high-fat diet were modeled for obese mice lipotoxic cardiomyopathy over a24-week feeding. The mice in the high-fat diet with nicotinamide ribose group were administered with 40 mmol/L nicotinamide ribose in drinking water for 12 weeks on top of the high-fat diet. After modeling, all mice were measured for blood pressure of the caudal artery, collected of peripheral blood samples for testing of blood sugar, and lipids, and evaluated for heart function by echocardiography. Then the mice hearts were harvested and subjected to pathological and molecular biological studies. The heart weight and tibia length of the mice were measured by gross photography. The area of mice cardiomyocytes was quantified by staining with wheat germ agglutinin (WGA). Picrosirius red (PSR) staining was used to show the myocardial fibrosis in mice such that the effect of nicotinamide riboside on mice myocardial remodeling was evaluated. The lipid droplets infiltration in mice cardiomyocytes was examined by transmission electron microscopy. The protein expression levels of Sirt1 and Serca2a in mice cardiomyocytes were detected by Western blotting. Results:Compared with the control group, the mice on high-fat diet presented significant increases in body weight, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride and LDL-c levels (all P<0.05), and the elevation in these indicators indiced by high fat diet was alleviated by the addition of nicotinamide riboside (all P<0.05). The heart rate and blood sugar level in mice were not affected by high-fat diet with or without nicotinamide riboside. Compared with the control group, the mice on high-fat diet had higher or greater left ventricular ejection fraction and lower ratio of E to A peaks (E/A) on echocardiograpy (both P<0.05), and addition of nicotinamide riboside increased the left ventricular ejection fraction and E/A ratio (both P<0.05). Compared with the control group, the mice on high-fat diet had higher or greater ratio of heart weight to tibia length, cross-sectional area and collagen contents in cardiomyocytes of the left ventricle (all P<0.05), whereas addition of nicotinamide riboside was found to inhibit the myocardial hypertrophy and fibrosis as described above (all P<0.05). Compared with the control group, high-fat diet led to a significant increase in deposition of lipid droplets in the left ventricular myocardium[ (13.8±0.86) /100 μm 2 vs (4.7±0.51) /100 μm 2, P<0.05], while nicotinamide ribose could alleviate such lipid-induced myocardial fibrosis[ (6.2±0.77) /100 μm 2 vs (13.8±0.86) /100 μm 2, P=0.021]. Western blotting showed lower protein expression levels of Sirt1 in the lipotoxic myocardial tissues and sarco (endo) plasmic reticulum Ca 2+-ATPase (Serca2a), along with increased acetylation of Serca2a in mice on high-fat diet compared with the control group (all P<0.05), while nicotinamide riboside was shown to increase Sirt1 and Serca2a expression and promote Serca2a deacetylation (all P<0.05) . Conclusion:Nicotinamide riboside may alleviate high fat-induced lipotoxic cardiomyopathy by promoting Sirt1-mediated deacetylation of Serca2a.

Nicotinamide riboside alleviates hypoxia/reoxygenation injury in adult mouse cardiomyocytes via Sirt3-PGC-1α pathway

Nicotinamide Riboside-Driven Modulation of SIRT3/mtROS/JNK Signaling Pathways Alleviates Myocardial Ischemia-Reperfusion Injury

Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway

Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress

Nicotinamide Riboside Attenuates Injury of Mouse Diabetic Cardiomyopathy and Possible Mechanism

Protection Effect of Nicotinamide on Cardiomyoblast Hypoxia/re-Oxygenation Injury: Study of Cellular Mitochondrial Metabolism.

GW27-e0632 NR Reduced Myocardial Ischemia-Reperfusion Injury by Improving Mitochondrial Biogenesis and Reducing Excessive Autophagy Via Sirt3-PGC-1α/P53 Pathway

Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway

Neuregulin-1 promotes mitochondrial biogenesis, attenuates mitochondrial dysfunction, and prevents hypoxia/reoxygenation injury in neonatal cardiomyocytes

Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside

Role of nicotinamide riboside in lipotoxic cardiomyopathy: a mechanistic study

Nicotinamide Riboside, an NAD + Precursor, Protects Against Cardiac Mitochondrial Dysfunction in Fetal Guinea Pigs Exposed to Gestational Hypoxia

Effect of neuregulin-1 on cardiomyocyte apoptosis and oxidative damage under hypoxia reoxygenation

Nicotinamide mononucleotide protects septic hearts in mice via preventing cyclophilin F modification and lysosomal dysfunction

Acute Treatment with Nicotinamide Riboside Chloride Reduces Hippocampal Damage and Preserves the Cognitive Function of Mice with Ischemic Injury

The additive effects of nicotinamide mononucleotide and melatonin on mitochondrial biogenesis and fission/fusion, autophagy, and microRNA-499 in the aged rat heart with reperfusion injury

Nicotinamide Mononucleotide Administration Restores Redox Homeostasis via the Sirt3-Nrf2 Axis and Protects Aged Mice from Oxidative Stress-Induced Liver Injury

NAD + administration decreases microvascular damage following cardiac ischemia/reperfusion by restoring autophagic flux

The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells

Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels

Nicotinamide mononucleotide and melatonin counteract myocardial ischemia-reperfusion injury by activating SIRT3/FOXO1 and reducing apoptosis in aged male rats